Skip to main content

Table 2 Factors Influencing Polypharmacy (Simple Correlations)

From: Feedback of patient survey on medication improves the management of polypharmacy: a pilot trial

  Polypharmacy group
(n = 138)
Non polypharmacy group
(n = 269)
p-value
Age 75, n (%) 76 (55.1) 72 (26.8) < 0.001
Male, n (%) 70 (50.7) 150 (55.8) 0.334
Number of family doctors 2, n (%) 81 (58.7) 92 (34.2) < 0.001
Feeling prescriptions were necessary, n (%) 111 (80.5) 195 (72.1) 0.079
Understanding reason for prescriptions, n (%) 125 (90.6) 252 (93.7) 0.257
Anxiety about reducing medicine, n (%) 66 (47.8) 165 (39.0) 0.089
Difficulty talking about reducing medicine, n (%) 34 (24.6) 33 (12.3) 0.001
  1. Univariate analyses showed significant differences between the polypharmacy group and the non-polypharmacy group in terms of the following 3 items: age, medical institutions visited for medical care, and the difficulty that patients had with asking their doctors to deprescribe their medications
\